Shareholding1 Oct 2026, 10:22 am
India Business Excellence Fund III Sells Molbio Diagnostics Shares
AI Summary
India Business Excellence Fund III has sold 23,77,627 equity shares of Molbio Diagnostics Limited, representing a 2.07% stake. The sale occurred on September 30, 2026. Prior to the transaction, the fund held 1,02,76,750 shares, amounting to 8.92% of the total equity. After the sale, their holding reduced to 78,99,123 shares, representing 6.85% of the total equity. This sale triggered the disclosure requirements under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, as the disposal breached the 2% threshold.
Key Highlights
- India Business Excellence Fund III sold 23,77,627 Molbio Diagnostics shares.
- The sale represents a 2.07% reduction in the fund's shareholding.
- Holding decreased from 8.92% to 6.85% post-transaction.
- Transaction occurred on September 30, 2026.
- Disclosure filed under SEBI (SAST) Regulations, 2011.
Price Impact
More from MOLBIO